Company intelligence / Profile preview

Philmedi

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Philmedi has launched commercial drug test kits for GHB, methamphetamine, and cocaine, and offers an AI-enabled menstrual cycle/hormone diagnostic app. Their molecular diagnostic platforms for infectious diseases are in development, with significant accuracy demonstrated in self-testing apps (95%+ diagnostic accuracy). Their pipeline spans from commercial to development stages, targeting rapid, affordable, and easy-to-use POC diagnostics for consumer and professional settings[1][2][3][5][6][7].

Therapeutic areas: Infectious DiseasesEndocrinologyPsychiatry
Modalities: DeviceAI-based diagnosticsMolecular diagnostic platformColorimetric detection platform
Industry: Molecular Diagnostics

Partnerships

Foundation for Innovative Diagnostics (FIND, mentioned as an investor/partner in diagnostics)[1]Law enforcement and customs agencies (product targets these professionals; possible partnerships implied)[4][6]

Beyond the preview

Go deeper on Philmedi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Philmedi.

Explore the full profile